Further studies characterizing the effect on DDR pathways and the longer-term effects of CFAP410 variants on genome stability could shed light on the possible mechanisms by which Cfap410 functional variants contribute to ALS risk. The gene discussed is CFAP410; the disease is amyotrophic lateral sclerosis.